DaeJeon, South Korea

Soon H An

This inventor holds 1 USPTO granted patent. Top assignee: Lucky Limited. Active years: 1990.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Soon H An. Retrieved from https://idiyas.com/inventor/soon-h-an

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 1990

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Soon H An in Cephalosporin Compounds

Introduction

Soon H An is a notable inventor based in Daejeon-Si, South Korea. He has made significant contributions to the field of antimicrobial agents, particularly through his work on cephalosporin compounds. His innovative approach has led to the development of novel compounds that exhibit high antimicrobial activity.

Latest Patents

Soon H An holds a patent for cephalosporin compounds, which are characterized by their formula (I). The invention relates to compounds that demonstrate enhanced antimicrobial properties. The patent highlights the potential of these compounds in medical applications, particularly in combating bacterial infections.

Career Highlights

Currently, Soon H An is associated with Lucky Limited, where he continues to advance his research in pharmaceuticals. His work has garnered attention for its potential impact on public health and the treatment of infectious diseases.

Collaborations

He has collaborated with notable colleagues, including Hun S Oh and Yong Z Kim, who share his commitment to innovation in the pharmaceutical industry.

Conclusion

Soon H An's contributions to the field of cephalosporin compounds exemplify the importance of innovation in developing effective antimicrobial agents. His work not only enhances our understanding of these compounds but also paves the way for future advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…